Somewhat Favorable News Coverage Somewhat Unlikely to Impact Polarityte (COOL) Stock Price
Media headlines about Polarityte (NASDAQ:COOL) have trended somewhat positive on Sunday, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Polarityte earned a news impact score of 0.14 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 45.4182699052876 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Polarityte (NASDAQ COOL) traded up $0.83 during trading on Friday, hitting $23.18. 166,590 shares of the stock traded hands, compared to its average volume of 135,938. The company has a market capitalization of $152.27, a PE ratio of -0.88 and a beta of 0.72. Polarityte has a twelve month low of $3.16 and a twelve month high of $32.63.
TRADEMARK VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Polarityte (COOL) Stock Price” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://theolympiareport.com/2017/12/24/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-polarityte-cool-stock-price.html.
PolarityTE, Inc, formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves.
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with Analyst Ratings Network's FREE daily email newsletter.